АЛГОРИТМ ДИАГНОСТИКИ ЗАБОЛЕВАНИЙ ШЕЙКИ МАТКИ И ВЕДЕНИЯ БЕРЕМЕННЫХ ЖЕНЩИН, ИНФИЦИРОВАННЫХ ВПЧ

1. Niyibizi J., Zanré N., Mayrand M.-H., Trottier H. The association between adverse pregnancy outcomes and maternal human papillomavirus infection: A systematicreview protocol. Systematic Reviews. 2017; 6(1): 56. https://dx.doi.org/10.1186/s13643-017-0443-5.

2. Бебнева Т.Н., Дикке Г.Б. Интраэпителиальные поражения шейки матки низкой степени риска у беременных женщин с ВПЧ и нарушениями биоценозавлагалища. Акушерство и гинекология. 2018; 11: 152-8. https://dx.doi.org/10.18565/aig.2018.11.152-158.

3. Al-Halal H., Kezouh A., Abenhaim H. Incidence and obstetrical outcomes of cervical intraepithelial neoplasia and cervical cancer in pregnancy: A population-basedstudy on 8.8 million births. Arch Gynecol Obstet. 2012; 287 (2). https://dx.doi.org/10.1007/s00404-012-2475-3.

4. Mailath-Pokorny M., Schwameis R., Grimm C., Reinthaller A., Polterauer S. Natural history of cervical intraepithelial neoplasia in pregnancy: postpartum histopathologic outcome and review of the literature. BMC Pregnancy Childbirth. 2016; 16: 74. https://dx.doi.org/10.1186/s12884-016-0861-8.

5. Shiping Z., Lushan Z.Q. et al. Progress in diagnosis and treatment of pregnancy complicated with cervical cancer. J Pract Med. 2018; 25(4): 400-2. https://dx.doi.org/10.1002/cam4.2435.

6. Sreeja S.R., Lee H.Y., Kwon M., Shivappa N., Hebert J.R., Kim M.K. Dietary Inflammatory Index and Its Relationship with Cervical Carcinogenesis Risk in KoreanWomen: A Case-Control Study. Cancers (Basel). 2019; 11(8): 1108. https://dx.doi.org/10.3390/cancers11081108.

7. Бебнева Т.Н., Дикке Г.Б. Рецидивирующие нарушения биоценоза влагалища, ассоциированные с бактериальным вагинозом, у беременных женщин сВПЧ-инфекцией. Акушерство и гинекология. 2018; 9: 52-8. https://dx.doi.org/10.18565/aig.2018.9.55-60.

8. Mitra A., MacIntyre D., Lee Y., Smith A., Marchesi J., Lehne B. et al. Characterisation of the vaginal microbiome in cervical intraepithelial neoplasia. Lancet. 2016;387: 75. https://dx.doi.org/10.1016/S0140-6736(16)00462-1.

9. Xiong Y.-Q., Mo Y., Luo Q.-M., Huo S.-T., He W.-Q., Chen Q. The Risk of Human Papillomavirus Infection for Spontaneous Abortion, Spontaneous Preterm Birth,and Pregnancy Rate of Assisted Reproductive Technologies: A Systematic Review and Meta-Analysis. Gynecol Obstet Invest. 2018; 83: 417-27. https://dx.doi.org/10.1159/000482008.

10. Бебнева Т.Н., Дикке Г.Б. Риск невынашивания и недонашивания беременности у женщин с ВПЧ-инфекцией и рецидивирующими нарушениями биоценоза влагалища. Акушерство и гинекология. 2019; 2: 135-42. https://dx.doi.org/10.18565/aig.2019.2.135-142.

11. Koliopoulos G., Nyaga V.N., Santesso N., Bryant A., Martin-Hirsch P.P.L., Mustafa R.A., Schünemann H. et al. Cytology versus HPV testing for cervical cancer screeningin the general population (Review). Cochrane Database of Systematic Reviews. 2017; Issue 8: CD008587. https://dx.doi.org/10.1002/14651858.CD008587.pub2.

12. Du X., Jiang S., Liu A. et al. Comparison of HPV testing by real–time fluorescent PCR and hc2 for detection of high–grade cervical intraepithelial neoplasia andcancer: a case–control study in high–risk patients. Biomedical. Research. 2018; 29 (1): 203-8. https://dx.doi.org/10.4066/biomedicalresearch.29-17-2964.

13. Zhou H., Mody R.R., Luna E., Armylagos D., Xu J., Schwartz M.R., Mody D.R., Ge Y. Clinical performance of the Food and Drug Administration-Approved high-riskHPV test for the detection of high-grade cervicovaginal lesions. Cancer Cytopathol. 2016; 124(5): 317-23. https://dx.doi.org/10.1002/cncy.21687.

14. Burd E.M. Human papillomavirus laboratory testing: the changing paradigm. Clin. Microbiol. Rev. 2016; 29: 291-319. https://dx.doi.org/10.1128/CMR.00013-15.

15. Marks M. et al, Kinetics of DNA load predict HPV 16 viral clearance. J ClinVirol. 2011; 51 (1): 44-9. https://dx.doi.org/10.1016/j.jcv.2011.01.011.

16. Nishio H., Iwata T., Nomura H., Morisada T., Takeshima N., Takano H., Sasaki H., Nakatani E., Teramukai S., Aoki D. Liquid-based cytology versus conventionalcytology for detection of uterine cervical lesions: a prospective observational study. Jpn J Clin Oncol. 2018; 48(6): 522-8. https://dx.doi.org/10.1093/jjco/hyy050.

17. Ciavattini A., Serri M., Di Giuseppe J., Liverani C.A., Fallani M.G., Tsiroglou D. et al. Reliability of colposcopy during pregnancy. Eur J Obstet Gynecol Reprod Biol.2018; 229: 76-81. https://dx.doi.org/10.1016/j.ejogrb.2018.07.029.

18. Gaydos C.A., Beqaj S., Schwebke J.R. et al. Clinical Validation of a Test for the Diagnosis of Vaginitis. Obstet Gynecol. 2017; 130(1): 181-9.https://dx.doi.org/10.1097/AOG.0000000000002090.

19. Zhou X., Bent S.J., Schneider M.G., Davis C.C., Islam M.R., Forney L.J. Characterization of vaginal microbial communities in adult healthy women using cultivationindependent methods. Microbiology (Reading). 2004; 150(Pt 8): 2565-73. https://dx.doi.org/10.1099/mic.0.26905-0. PMID: 15289553.